Over 150 Total Lots Up For Auction at One Location - NY 04/18

Charlie Powell

21st Century Oncology hires chief operating officer
January 11, 2019
Business Affairs
Charlie Powell
FORT MYERS, Fla., Jan. 7, 2019 /PRNewswire/ -- 21st Century Oncology has announced that Charlie Powell, CMPE, FACHE joined the company as the Chief Operating Officer on Jan. 1, 2019. A premier cancer care provider, the company welcomes Powell as the newest member of their "One Dream Team."

Powell brings an extensive background in physician practice, ambulatory facility, and hospital leadership experience in health systems, as well as private practices. Powell's impressive accomplishments in establishing physician-led governance structures, increasing quality, safety and service scores and improving revenue cycle operations as well as his expertise in turnaround, population health, and strategic planning align well with the new 21st Century Oncology's vision for the future.

Powell joins 21st Century Oncology from KentuckyOne Health in Louisville, Kentucky where he served as the President, Physician Enterprise and Ambulatory for Sts. Mary and Elizabeth Hospital. In these positions, Powell improved patient satisfaction and quality measures, hospital operating performance, and achieved the top quartile CG-CAHPS access scores in the medical group.

In addition to his accomplishments at KentuckyOne Health, Powell held positions at Saint Thomas Health in Nashville, Tennessee as CEO, Physician Services and CEO, Saint Thomas Heart. He also served as CEO, Northeast Georgia Heart Center in Gainesville, Georgia and COO, Piedmont HealthCare in Statesville, North Carolina.

"Over the past year, we have been fortunate to continue to expand our leadership team with extraordinary health care leaders. Charlie is no exception and will play a key role in our expansion and evolution this year. We are excited to have Charlie joining our Dream Team and taking our operational performance to the next level," said Kim Commins-Tzoumakas, CEO of 21st Century Oncology.


About 21st Century Oncology
21st Century Oncology is the largest global provider of Integrated Cancer Care services that strongly believes in fighting for patients like an army and caring for them like a family. Operating as one dream team in the crusade against cancer, the company employs or is affiliated with more than 928 physicians globally to deliver the most advanced, integrated, and compassionate cancer care in personal and convenient settings. Headquartered in Fort Myers, FL, 21st Century Oncology operates 169 treatment centers.


SOURCE 21st Century Oncology

Back to HCB News

You Must Be Logged In To Post A Comment

 

advertisement

Business Affairs Homepage

Understanding healthcare's big shift toward outpatient facilities from a real estate perspective
New report from JLL sheds light on motives and advantages
STERIS to divest its dental segment to Peak Rock Capital for $787 million
Sale allows company to focus on core markets including healthcare, pharmaceuticals, and medtech
RadNet expands Houston presence with acquisition of six imaging centers
Will rebrand them under the Houston Medical Imaging banner
Massive Stark Law settlement underscores continued government scrutiny of health system physician employment arrangements
Insights from Joseph Keillor, healthcare attorney with Baker Donelson
Strategic reference-based pricing: A cure for the medical overbilling epidemic
Insights from Christine Cooper, CEO of aequum LLC
Peter S. Fine retires from Banner Health after 24 years as CEO
Amy Perry, currently the president of Banner Health, will assume the role
KARL STORZ enters talks to acquire Asensus Surgical for $95 million
Surgical robot developer is a pioneer in digitizing surgical procedures
Medical Properties Trust finalizes sale of five medical facilities to Prime Healthcare for $350 million
Part of a strategic realignment between the two entities
Mercy to build $650 million hospital in Missouri
Health system’s response to increasing population in three counties
Federal court issues consent decree to Philips Respironics for recall remediation
Mandate restricts production and distribution of new sleep therapy machines